New polymorphic forms of dihydrogen phosphate - 6 - (1 - methyl - 1h-pyrazol-4-yl) - 2 - (3 - 5 - (2 - (4 - il - ethoxy) - pyrimidin-2-yl) - Benzyl - il - 2} - 2H - pyridazin-3 3-one and processes for its preparation

摘要

Referring to the dihydrogen phosphate - 6 - (1 - methyl - 1h-pyrazol-4-yl) - 2 - (3 - [5 - (2 - (4 - il - extoxi - pyrimidin-2-yl) - yl] - Benzyl - 2} - 2H - pyridazin-3 3-one, their forms and solvates clear as Crystal form A1 characterized by XRD Peaks 18,4u00ba, 18,8u00ba, 23,7u00ba, 24,2u00ba, 26,4u00ba and 28,2u00ba 2 Theta ( u00b10,1u00ba 2theta) emepleando cu Radiation kalfa1 or Crystalline form H1 with Peaks of XRD 3,1u00ba, 94th and 18,8u00ba 2 Theta (u00b10,1u00ba 2theta). Farmaceutca also relates to a Composition and a process of Preparation. These compounds are useful in the treatment of diseases mediated by Kinases